DILLARDS INC-CL A (DDS) Fundamental Analysis & Valuation
NYSE:DDS • US2540671011
Current stock price
595.71 USD
-11 (-1.81%)
At close:
596.87 USD
+1.16 (+0.19%)
After Hours:
This DDS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DDS Profitability Analysis
1.1 Basic Checks
- DDS had positive earnings in the past year.
- In the past year DDS had a positive cash flow from operations.
- DDS had positive earnings in each of the past 5 years.
- In the past 5 years DDS always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of DDS (16.27%) is better than 100.00% of its industry peers.
- DDS has a better Return On Equity (32.05%) than 96.77% of its industry peers.
- DDS has a better Return On Invested Capital (20.96%) than 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for DDS is significantly above the industry average of 8.75%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.27% | ||
| ROE | 32.05% | ||
| ROIC | 20.96% |
ROA(3y)18.17%
ROA(5y)21.57%
ROE(3y)36.21%
ROE(5y)44.77%
ROIC(3y)23.62%
ROIC(5y)29.53%
1.3 Margins
- DDS's Profit Margin of 8.69% is amongst the best of the industry. DDS outperforms 83.87% of its industry peers.
- DDS's Profit Margin has declined in the last couple of years.
- DDS has a better Operating Margin (10.18%) than 77.42% of its industry peers.
- In the last couple of years the Operating Margin of DDS has declined.
- With a Gross Margin value of 40.32%, DDS is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
- DDS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.18% | ||
| PM (TTM) | 8.69% | ||
| GM | 40.32% |
OM growth 3Y-13.99%
OM growth 5YN/A
PM growth 3Y-11.99%
PM growth 5YN/A
GM growth 3Y-2.17%
GM growth 5Y5.56%
2. DDS Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DDS is creating value.
- The number of shares outstanding for DDS has been reduced compared to 1 year ago.
- DDS has less shares outstanding than it did 5 years ago.
- DDS has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 8.77 indicates that DDS is not in any danger for bankruptcy at the moment.
- DDS's Altman-Z score of 8.77 is amongst the best of the industry. DDS outperforms 96.77% of its industry peers.
- The Debt to FCF ratio of DDS is 0.84, which is an excellent value as it means it would take DDS, only 0.84 years of fcf income to pay off all of its debts.
- DDS has a better Debt to FCF ratio (0.84) than 87.10% of its industry peers.
- A Debt/Equity ratio of 0.24 indicates that DDS is not too dependend on debt financing.
- DDS has a Debt to Equity ratio of 0.24. This is in the better half of the industry: DDS outperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | 0.84 | ||
| Altman-Z | 8.77 |
ROIC/WACC2.33
WACC9.01%
2.3 Liquidity
- A Current Ratio of 2.65 indicates that DDS has no problem at all paying its short term obligations.
- DDS has a better Current ratio (2.65) than 93.55% of its industry peers.
- DDS has a Quick Ratio of 1.31. This is a normal value and indicates that DDS is financially healthy and should not expect problems in meeting its short term obligations.
- DDS has a Quick ratio of 1.31. This is comparable to the rest of the industry: DDS outperforms 54.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.65 | ||
| Quick Ratio | 1.31 |
3. DDS Growth Analysis
3.1 Past
- The earnings per share for DDS have decreased by -1.30% in the last year.
- Measured over the past years, DDS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.53% on average per year.
- The Revenue has decreased by -0.41% in the past year.
- Measured over the past years, DDS shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)-1.3%
EPS 3Y-10.53%
EPS 5YN/A
EPS Q2Q%-3.19%
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.11%
Revenue growth 5Y8.16%
Sales Q2Q%-3.03%
3.2 Future
- The Earnings Per Share is expected to decrease by -0.05% on average over the next years.
- Based on estimates for the next years, DDS will show a small growth in Revenue. The Revenue will grow by 1.11% on average per year.
EPS Next Y-7.97%
EPS Next 2Y-3.64%
EPS Next 3Y-0.05%
EPS Next 5YN/A
Revenue Next Year-0.3%
Revenue Next 2Y0.39%
Revenue Next 3Y1.11%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. DDS Valuation Analysis
4.1 Price/Earnings Ratio
- DDS is valuated correctly with a Price/Earnings ratio of 16.36.
- Compared to the rest of the industry, the Price/Earnings ratio of DDS indicates a somewhat cheap valuation: DDS is cheaper than 77.42% of the companies listed in the same industry.
- DDS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.78, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 17.78, DDS is valued on the expensive side.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of DDS is on the same level as its industry peers.
- The average S&P500 Price/Forward Earnings ratio is at 23.54. DDS is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.36 | ||
| Fwd PE | 17.78 |
4.2 Price Multiples
- 83.87% of the companies in the same industry are more expensive than DDS, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of DDS indicates a somewhat cheap valuation: DDS is cheaper than 70.97% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.92 | ||
| EV/EBITDA | 10.06 |
4.3 Compensation for Growth
- DDS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.64%
EPS Next 3Y-0.05%
5. DDS Dividend Analysis
5.1 Amount
- DDS has a yearly dividend return of 0.20%, which is pretty low.
- DDS's Dividend Yield is a higher than the industry average which is at 0.69.
- Compared to an average S&P500 Dividend Yield of 1.83, DDS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
- The dividend of DDS is nicely growing with an annual growth rate of 15.52%!
- DDS has been paying a dividend for at least 10 years, so it has a reliable track record.
- DDS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.52%
Div Incr Years15
Div Non Decr Years34
5.3 Sustainability
- 85.04% of the earnings are spent on dividend by DDS. This is not a sustainable payout ratio.
- The Dividend Rate of DDS has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP85.04%
EPS Next 2Y-3.64%
EPS Next 3Y-0.05%
DDS Fundamentals: All Metrics, Ratios and Statistics
595.71
-11 (-1.81%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)02-24 2026-02-24/bmo
Earnings (Next)05-11 2026-05-11
Inst Owners67.82%
Inst Owner Change0%
Ins Owners23.14%
Ins Owner Change-1.41%
Market Cap9.30B
Revenue(TTM)6.56B
Net Income(TTM)570.19M
Analysts45.45
Price Target566.1 (-4.97%)
Short Float %10.16%
Short Ratio5.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend30.77
Dividend Growth(5Y)15.52%
DP85.04%
Div Incr Years15
Div Non Decr Years34
Ex-Date03-31 2026-03-31 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.38%
Min EPS beat(2)21.78%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)22.9%
Min EPS beat(4)12.59%
Max EPS beat(4)34.25%
EPS beat(8)7
Avg EPS beat(8)17.04%
EPS beat(12)11
Avg EPS beat(12)22.12%
EPS beat(16)15
Avg EPS beat(16)40.79%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)2.62%
Revenue beat(4)2
Avg Revenue beat(4)0.15%
Min Revenue beat(4)-2.96%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)0.09%
Revenue beat(12)7
Avg Revenue beat(12)0.26%
Revenue beat(16)10
Avg Revenue beat(16)1.07%
PT rev (1m)-1.13%
PT rev (3m)-1.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.57%
EPS NY rev (1m)-0.61%
EPS NY rev (3m)3.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.36 | ||
| Fwd PE | 17.78 | ||
| P/S | 1.42 | ||
| P/FCF | 14.92 | ||
| P/OCF | 12.98 | ||
| P/B | 5.23 | ||
| P/tB | 5.23 | ||
| EV/EBITDA | 10.06 |
EPS(TTM)36.41
EY6.11%
EPS(NY)33.51
Fwd EY5.62%
FCF(TTM)39.92
FCFY6.7%
OCF(TTM)45.9
OCFY7.71%
SpS420.19
BVpS113.89
TBVpS113.89
PEG (NY)N/A
PEG (5Y)N/A
Graham Number305.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.27% | ||
| ROE | 32.05% | ||
| ROCE | 25.66% | ||
| ROIC | 20.96% | ||
| ROICexc | 35.66% | ||
| ROICexgc | 35.66% | ||
| OM | 10.18% | ||
| PM (TTM) | 8.69% | ||
| GM | 40.32% | ||
| FCFM | 9.5% |
ROA(3y)18.17%
ROA(5y)21.57%
ROE(3y)36.21%
ROE(5y)44.77%
ROIC(3y)23.62%
ROIC(5y)29.53%
ROICexc(3y)38.49%
ROICexc(5y)45.64%
ROICexgc(3y)38.49%
ROICexgc(5y)45.64%
ROCE(3y)28.92%
ROCE(5y)36.15%
ROICexgc growth 3Y-13.29%
ROICexgc growth 5YN/A
ROICexc growth 3Y-13.29%
ROICexc growth 5YN/A
OM growth 3Y-13.99%
OM growth 5YN/A
PM growth 3Y-11.99%
PM growth 5YN/A
GM growth 3Y-2.17%
GM growth 5Y5.56%
F-Score6
Asset Turnover1.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | 0.84 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 51.63% | ||
| Cap/Sales | 1.42% | ||
| Interest Coverage | 16.33 | ||
| Cash Conversion | 84.48% | ||
| Profit Quality | 109.37% | ||
| Current Ratio | 2.65 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 8.77 |
F-Score6
WACC9.01%
ROIC/WACC2.33
Cap/Depr(3y)61.09%
Cap/Depr(5y)59.66%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.65%
Profit Quality(3y)104.56%
Profit Quality(5y)108.58%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.3%
EPS 3Y-10.53%
EPS 5YN/A
EPS Q2Q%-3.19%
EPS Next Y-7.97%
EPS Next 2Y-3.64%
EPS Next 3Y-0.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.11%
Revenue growth 5Y8.16%
Sales Q2Q%-3.03%
Revenue Next Year-0.3%
Revenue Next 2Y0.39%
Revenue Next 3Y1.11%
Revenue Next 5YN/A
EBIT growth 1Y-6.66%
EBIT growth 3Y-15.8%
EBIT growth 5YN/A
EBIT Next Year12.79%
EBIT Next 3Y9.18%
EBIT Next 5YN/A
FCF growth 1Y2.32%
FCF growth 3Y-9.03%
FCF growth 5Y26.52%
OCF growth 1Y0.41%
OCF growth 3Y-8.9%
OCF growth 5Y23.17%
DILLARDS INC-CL A / DDS Fundamental Analysis FAQ
What is the fundamental rating for DDS stock?
ChartMill assigns a fundamental rating of 6 / 10 to DDS.
Can you provide the valuation status for DILLARDS INC-CL A?
ChartMill assigns a valuation rating of 5 / 10 to DILLARDS INC-CL A (DDS). This can be considered as Fairly Valued.
Can you provide the profitability details for DILLARDS INC-CL A?
DILLARDS INC-CL A (DDS) has a profitability rating of 7 / 10.
What is the financial health of DILLARDS INC-CL A (DDS) stock?
The financial health rating of DILLARDS INC-CL A (DDS) is 7 / 10.
Is the dividend of DILLARDS INC-CL A sustainable?
The dividend rating of DILLARDS INC-CL A (DDS) is 4 / 10 and the dividend payout ratio is 85.04%.